Minimally Invasive Partial Versus Total Adrenalectomy for the Treatment of Primary Aldosteronism: Results of a Multicenter Series According to the PASO Criteria
- PMID: 32660839
- DOI: 10.1016/j.euf.2020.06.023
Minimally Invasive Partial Versus Total Adrenalectomy for the Treatment of Primary Aldosteronism: Results of a Multicenter Series According to the PASO Criteria
Abstract
Background: Determination of success after adrenal-sparing surgery for primary aldosteronism (PA) is limited by the lack of standardized definitions of outcomes.
Objective: To evaluate the safety and effectiveness of minimally invasive partial adrenalectomy (MIPA) for PA by comparing perioperative and functional outcomes with minimally invasive total adrenalectomy (MITA) according to the Primary Aldosteronism Surgical Outcome (PASO) criteria.
Design, setting, and participants: Between March 2011 and April 2020, a multicenter adrenalectomy dataset was queried for "unilateral adrenal mass, PA, MIPA (n = 29), or MITA (n = 61)"at four participating Institutions.
Intervention: MITA and MIPA for PA.
Outcome measurements and statistical analysis: Differences between continuous variables were assessed with the Wilcoxon rank sum test, while Pearson's χ2 test was used for categorical data. Complete, partial, and absent clinical success rates were assessed for the overall cohort and compared between groups.
Results and limitations: The median tumor size was significantly higher in the MITA group (4.2 vs 2.7 cm; p = 0.001), while preoperative hypertension rate was significantly higher in the MIPA series (82.8% vs 57.4%, p = 0.01). The median length of hospital stay was increased in the MITA cohort (4 vs 3 d; p = 0.038). Overall, at a median follow-up of 42 mo (interquartile range 27-54 mo), complete, partial, and absent clinical success was observed in 60%, 17.7%, and 22.3% of cases, respectively. The complete clinical success rate was higher in the MIPA group (72.4% vs 54.1%), while a partial clinical success was higher in the MITA series (23% vs 6.8%). The absence of clinical success was comparable between groups (MITA 23% vs MIPA 20.7%).
Conclusions: MIPA showed excellent perioperative results with a complete clinical success rate of 72.4%. Owing to the heterogeneity of the PASO criteria in the assessment of partial or absent success, the quest for a univocal definition of satisfactory clinical outcomes in the treatment of PA remains open.
Patient summary: We compared minimally invasive partial adrenalectomy (MIPA) and minimally invasive total adrenalectomy for the treatment of unilateral primary aldosteronism, assessing the outcomes with the Primary Aldosteronism Surgical Outcome (PASO) criteria. MIPA seems to provide comparable perioperative outcomes and midterm clinical success rates.
Keywords: Laparoscopy; Outcomes; PASO; Partial adrenalectomy; Primary aldosteronism; Robotics.
Copyright © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Re-evaluating absent clinical success after adrenalectomy in unilateral primary aldosteronism.Surgery. 2021 Nov;170(5):1389-1396. doi: 10.1016/j.surg.2021.05.038. Epub 2021 Jun 25. Surgery. 2021. PMID: 34183182
-
Refining the Definitions of Biochemical and Clinical Cure for Primary Aldosteronism Using the Primary Aldosteronism Surgical Outcome (PASO) Classification System.World J Surg. 2018 Feb;42(2):453-463. doi: 10.1007/s00268-017-4311-1. World J Surg. 2018. PMID: 29134312
-
Minimally invasive partial versus total adrenalectomy for unilateral primary hyperaldosteronism-a retrospective, multicenter matched-pair analysis using the new international consensus on outcome measures.Surgery. 2021 Jun;169(6):1361-1370. doi: 10.1016/j.surg.2020.09.005. Epub 2020 Oct 17. Surgery. 2021. PMID: 33077201
-
Minimally Invasive Partial vs. Total Adrenalectomy for the Treatment of Unilateral Primary Aldosteronism: A Systematic Review and Meta-Analysis.J Clin Med. 2022 Feb 25;11(5):1263. doi: 10.3390/jcm11051263. J Clin Med. 2022. PMID: 35268355 Free PMC article. Review.
-
[Risk factors of persistent hypertension in primary aldosteronism patients after surgery].Beijing Da Xue Xue Bao Yi Xue Ban. 2022 Aug 18;54(4):686-691. doi: 10.19723/j.issn.1671-167X.2022.04.017. Beijing Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 35950393 Free PMC article. Review. Chinese.
Cited by
-
Therapeutic Outcomes with Surgical and Medical Management of Primary Aldosteronism.Curr Cardiol Rep. 2021 Jun 3;23(7):89. doi: 10.1007/s11886-021-01516-0. Curr Cardiol Rep. 2021. PMID: 34081226 Free PMC article. Review.
-
Robotic Versus Laparoscopic Adrenalectomy for Adrenal Tumors: An Up-to-Date Meta-Analysis on Perioperative Outcomes.Cancers (Basel). 2025 Jan 5;17(1):150. doi: 10.3390/cancers17010150. Cancers (Basel). 2025. PMID: 39796777 Free PMC article. Review.
-
Comparison of postoperative biochemical indicators and surgical result between partial adrenalectomy and total adrenalectomy: a systematic review and meta-analysis.Gland Surg. 2024 Dec 31;13(12):2274-2287. doi: 10.21037/gs-24-345. Epub 2024 Dec 27. Gland Surg. 2024. PMID: 39822352 Free PMC article.
-
Adrenalectomy for primary aldosteronism and its related surgical characteristics.Front Endocrinol (Lausanne). 2024 Jun 20;15:1416287. doi: 10.3389/fendo.2024.1416287. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38966219 Free PMC article. Review.
-
Modified versus three-level technique of retroperitoneal laparoscopic adrenalectomy for all patients with adrenal lesions ≤ 6cm: a retrospective, case-controlled study.Front Endocrinol (Lausanne). 2024 Mar 4;15:1342240. doi: 10.3389/fendo.2024.1342240. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38501101 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous